Autophagy Inhibition Synergizes with Immunotherapy in Pancreatic Cancer.

{"title":"Autophagy Inhibition Synergizes with Immunotherapy in Pancreatic Cancer.","authors":"","doi":"10.1158/2159-8290.CD-RW2020-063","DOIUrl":null,"url":null,"abstract":"Autophagy-mediated MHC-I degradation facilitated immune evasion in pancreatic ductal adenocarcinoma.","PeriodicalId":502270,"journal":{"name":"Cancer Discovery","volume":"32 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/2159-8290.CD-RW2020-063","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

Autophagy-mediated MHC-I degradation facilitated immune evasion in pancreatic ductal adenocarcinoma.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
自噬抑制与胰腺癌免疫疗法协同作用
自噬介导的 MHC-I 降解促进了胰腺导管腺癌的免疫逃避。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
ALK+/EGFRm NSCLC: Lorlatinib Wows; Toward Sub-Q Amivantamab Cancer Hallmarks: Piecing the Puzzle Together. Continuing the Conversation. Metastasis Has Multiple Origins and Occurs Early in Tumorigenesis. Pembrolizumab May Enhance Current Treatments for Esophagogastric Cancers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1